Fluid Status of ESRD Patients Undergoing Dialysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

26 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-18

Study Completion Date

2025-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The pilot clinical study will assess the correlation between fluid removal during dialysis and HemoCept device data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fluid Status of Dialysis Subjects

NCT07217041

ESRD (End Stage Renal Disease)

COMPLETED

Clinical Evaluation of the CM-1500 During Hemodialysis

NCT05125848

Fluid Loss Dialysis

COMPLETED NA

Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function

NCT03874117

Hemodialysis Kidney Failure, Chronic

COMPLETED NA

Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis

NCT03901794

Hemodialysis Complication Hemodialysis-Induced Symptom

COMPLETED

Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients

NCT04603014

End Stage Renal Disease on Dialysis Hemodialysis Peritoneal Dialysis +1 more

ACTIVE_NOT_RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ESRD (End Stage Renal Disease)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject or representatives must have voluntarily signed the informed consent form before any study related procedures
* Subjects can be any gender, but must be between (and including) 18 and 75 years of age
* Subject has been on dialysis for more than 90 days and has been diagnosed with end stage kidney disease
* Subject is able and willing to provide informed consent and HIPAA authorization.
* Subject is able and willing to meet all study requirements
* Subject is able to place electrodes on bilateral deltoids and above the pant line on the waist.

Exclusion Criteria

* Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
* Subject has a personal medical history that includes: Long Q-T syndrome, Cardiac channelopathies, genetic heart defects, Seizures, Acute untreated blood clotting disorders or acute untreated bleeding disorders
* Subject has had a heart transplant.

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No